Investor Presentaiton
STRONG FINANCIAL TRACK RECORD
EBOS has delivered consistent financial performance through the cycle
Underlying EBITDA1:
(A$m)
13.5% CAGR²
Underlying EPS1:
(A$ cents per share)
10.8% CAGR²
437
129
115
336
367
159
182 208
228
250 262
289
86 90
94
101
77
66
57
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 H1
Return on capital employed:
(ROCE, %)
12
75
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 H1
FY23
FY23
DPS:
15% target
16.7% 17.1% 16.3% 15.9%
18.0% 18.6%
17.1%
14.6%
14.4%
12.9%
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 H1
FY233
(NZ$ cents per share)
11.2% CAGR²
59 63
69
41
47
~70% avg. payout
96
89
22
72
78
53
FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 H1
FY23
Total shareholder returns4:
15%
1 year
123%
3 year
560%
10 year
Notes: 1. Underlying earnings exclude the impact of one-off items. 2. CAGR calculation is inclusive of FY14-FY22. 3. ROCE for H1 FY23 incorporates the $1,167m acquisition of
LifeHealthcare. 4. Total shareholder return calculated as at 31 March 2023 and includes dividends.
EBOS
GROUP LIMITEDView entire presentation